Co-injection of cGAMP with PD-1 or CTLA-4 inhibitor exhibited an enhanced anti-tumor effect and increased tumor-infiltrating CD8+ T cell responses in a mouse model of melanoma and an ex vivo model of cultured human melanoma explants [52,53]. This evidence concerns the gene CD8A and neoplasm.